IL-13 BINDING AGENTS

Agents (e.g., antibodies and fragments thereof) that bind specifically to IL 13and modulate the ability of IL-13 to interact with IL-13 receptors and signaling mediatorsare disclosed. La presente invencion describe agentes (por ejemplo, anticuerpos y fragmentos de los mismos) que se unen especificam...

Full description

Saved in:
Bibliographic Details
Main Authors MACY X. JIN, DAVINDER GILL, SAMUEL J. GOLDMAN, LIOUDMILA TCHISTIAKOVA, ANGELA M. WIDOM, JOHN KNOPF, DEBRA D. DONALDSON, BRUCE JACOBSON, XIANG-YANG TAN, MARION T. KASAIAN
Format Patent
LanguageEnglish
Spanish
Published 23.03.2007
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
DERIVATIVES THEREOF
ENZYMOLOGY
FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
SUGARS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:Agents (e.g., antibodies and fragments thereof) that bind specifically to IL 13and modulate the ability of IL-13 to interact with IL-13 receptors and signaling mediatorsare disclosed. La presente invencion describe agentes (por ejemplo, anticuerpos y fragmentos de los mismos) que se unen especificamente a IL-13 y modulan la capacidad de la IL-13 para interactuar con los receptores de IL-13 y los mediadores de senalizacion.
Bibliography:Application Number: MX2006PA14564